Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitrectomy and rt-PA for submacular hemorrhage in RAM
NCT02120066Completed
- Sponsor
- Kyorin University
- Start
- Jan 2011
- Primary completion
- Jun 2013
- Countries
- 1
01
Overview
Open-label trial of tissue-plasminogen activator in submacular hemorrhage (SMH), sponsored by Kyorin University. Primary endpoint: Displacement of submacular hemorrhage at 1 year. Started Jan 2011; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
submacular hemorrhage (SMH)
Beyond the preview
Go deeper on NCT02120066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120066.